Skip to main content
PRFX
NASDAQ Life Sciences

FDA 批准 PRF Technologies 的 OcuRing™-K 进入 2 期试验，用于治疗白内障术后疼痛，推进关键药物候选物的开发

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
8
Price
$2.06
Mkt Cap
$1.934M
52W Low
$1.797
52W High
$17.95
Market data snapshot near publication time

summarizeSummary

PRF Technologies 宣布，FDA 已批准其对 OcuRing™-K 的新药调查（IND）申请，使得公司能够启动 2 期临床试验。OcuRing™-K 是一种新型的、无需眼药水的、可持续释放的眼科药物递送平台，旨在解决白内障术后疼痛和炎症的问题。这一监管批准是临床阶段公司的一个重要里程碑，降低了资产风险，并将关键产品候选物推进到临床开发的下一阶段。对于像该公司这样规模的公司来说，进入 2 期是一个向大型白内障手术市场潜在进入的关键步骤。投资者现在将监测计划于 2026 年下半年启动的多中心 2 期试验及其后的数据发布。

在该公告发布时，PRFX的交易价格为$2.06，交易所为NASDAQ，所属行业为Life Sciences，市值约为$193.4万。 52周交易区间为$1.80至$17.95。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed PRFX - Latest Insights

PRFX
Apr 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
FDA Clears PRF Technologies' OcuRing™-K for Phase II Trial in Post-Cataract Pain, Advancing Key Drug Candidate
Sentiment: Positive
View Wiseek Article
PRFX
Mar 27, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
8
PRF Technologies Details Strategic Progress, Reduced Losses, and Strong Cash Position in Year-End Update
Sentiment: Positive
View Wiseek Article
PRFX
Mar 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
PRF Technologies Reports Strong 2025 Progress: $4.1M Cash, Key Solar Deals, and OcuRing-K Advancement
Sentiment: Positive
View Wiseek Article
PRFX
Mar 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
DeepSolar Platform Eyes Multiple 150MW+ Solar Deals via New Collaboration
Sentiment: Positive
View Wiseek Article
PRFX
Feb 18, 2026, 9:38 AM EST
Filing Type: 6-K
Importance Score:
8
PRF Technologies' DeepSolar Secures Due Diligence Engagement with Global Leader EDF Power Solutions
Sentiment: Positive
View Wiseek Article
PRFX
Feb 11, 2026, 8:54 AM EST
Filing Type: 6-K
Importance Score:
8
PRF Technologies Secures Commercial DeepSolar Deployment for 71 MW European Solar Project
Sentiment: Positive
View Wiseek Article
PRFX
Feb 03, 2026, 4:16 PM EST
Filing Type: 6-K
Importance Score:
8
PRF Technologies Announces 1-for-5 Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article
PRFX
Jan 20, 2026, 9:07 AM EST
Filing Type: 6-K
Importance Score:
7
PRF Technologies Files First Patent for Solar Micro-Climate Forecasting
Sentiment: Positive
View Wiseek Article
PRFX
Jan 15, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
PainReform Rebrands to PRF Technologies, Signaling Strategic Diversification into AI-Driven Energy and Expanded Healthcare
Sentiment: Positive
View Wiseek Article
PRFX
Jan 12, 2026, 9:10 AM EST
Filing Type: 6-K
Importance Score:
7
PainReform's OcuRing™-K Platform Shows Favorable Safety in Phase I & Preclinical Studies
Sentiment: Positive
View Wiseek Article